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Abstract 
AIM: Both observational and experimental studies have 
shown that higher selenium status reduces the risk of upper 
gastrointestinal cancers in selenium deficient populations. 
Recent cancer registry data have shown very different rates 
of esophageal cancer (EC) and gastric cancer (GC) in four 
Provinces of Iran, namely Ardabil, Mazandaran, Golestan, 
and Kerman. The aim of this study was to have a 
preliminary assessment of the hypothesis that high rates 
of EC in Golestan and high rates of GC in Ardabil may be 
partly attributable to selenium deficiency. 
METHODS: We measured serum selenium in 300 healthy 
adults from Ardabil (n = 100), Mazandaran (n = 50), Golestan 
(n = 100), and Kerman (n = 50), using inductively coupled 
plasma, with dynamic reaction cell, mass spectrometry (ICP­
DRC-MS) at the US Centers for Disease Control (Atlanta, 
Georgia). 
RESULTS: The median serum selenium concentrations were 
very different in the four Provinces. The medians (IQR) for 
selenium in Ardabil, Mazandarn, Golestan, and Kerman 
were 82 (75-94), 123 (111-132), 155 (141-173), and 119 
(110-128) µg/L, respectively (P<0.001). The results of linear 
regression showed that the Province variable, by itself, 
explained 76% of the variance in log selenium (r 2 = 0.76). 
The proportion of the populations with a serum selenium 
more than 90 µg/L (the concentration at which serum 
selenoproteins are saturated) was 100% in Golestan, 
Kerman, and Mazandaran but only 29% in Ardabil. 
CONCLUSION: Our findings suggest that selenium deficiency 
is not a major contributor to the high incidence of EC seen 
in northeastern Iran, but it may play a role in the high 
incidence of GC in Ardabil Province. 
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INTRODUCTION 
Esophageal cancer (EC) and gastric cancer (GC), collectively 
known as upper gastrointestinal (UGI) cancers, constitute 16% of 
all cancer deaths worldwide and are responsible for approximately 
one million deaths each year[1].
 Both observational and experimental studies have shown 
that higher selenium status reduces the risk of UGI cancers in 
selenium deficient populations[2-5]. In a large-scale, prospective 
cohort study conducted in Finland, a low selenium region prior 
to a current supplementation program, Knekt and colleagues 
found a lower risk of stomach cancer in individuals with higher 
baseline serum selenium concentrations[3]. In another large 
cohort study, Mark and colleagues also found a reduced risk 
of esophageal cancer and gastric cardia cancer among individuals 
with higher initial serum selenium concentrations in a selenium 
deficient population in Linxian, China[4]. A double-blind, 
randomized clinical trial in this same Chinese population showed 
a reduced risk of both cardia and non-cardia gastric cancers in 
individuals supplemented with a combination of selenium, beta-
carotene, and alpha-tocopherol[2]. 
Iran also has high rates of both EC and GC[6-8], and these 
cancers are the two most common causes of cancer death in 
Iran[9]. However, recent cancer registry data showed highly 
varying rates of EC and GC in four Provinces of Iran, namely 
Ardabil[7], Mazandaran, Golestan, and Kerman (unpublished 
data). The annual age-standardized incidence rates (ASRs) for 
EC were 15, 19, 40, and 3 per 105, and ASRs for GC were 38, 22, 
18, and 8 per 105 in these four Provinces, respectively. 
We hypothesized that differences in serum selenium may 
partly explain the highly varying rates of EC and GC in Iran. 
Here, we present the results of an ecologic study that compared 
serum selenium concentrations in randomly selected healthy 
subjects from Ardabil, Mazandaran, Golestan, and Kerman 
Provinces. 
MATERIALS AND METHODS 
Serum samples from 300 healthy adults were selected for this 
study. These subjects had all been recruited for previous 
studies. Ardabil serum samples (100 samples) were selected from 
participants in an endoscopic survey of gastric precancerous 
lesions conducted among rural and urban subjects >/=40 years 
old[10]. These subjects were selected using simple random 
sampling, and all resided in Meshkinshahr, a major city in 
Ardabil, or its surrounding villages. Mazandaran and Kerman 
serum samples (50 samples each) were selected from participants 
in a survey of the prevalence of celiac disease among urban 
inhabitants >/=18 years old in these two Provinces. These 
subjects were selected randomly from the entire urban 
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population of Sari and Kerman, the two major cities of these 
Provinces. In Golestan, 100 serum samples were selected from 
urban and rural individuals >/=40 years of age who were 
recruited during the pilot phase of a cohort study of UGI cancers. 
In all of these studies, the only inclusion criteria were residence, 
age, and lack of life-threatening conditions. All samples were 
collected in the years 2002 and 2003. From these subjects, we 
selected our study samples such that they represented male 
and female participants equally (Table 1). Samples from Ardabil 
and Golestan included both urban and rural populations, but 
samples from Kerman and Mazandaran represented only urban 
subjects. 
A single blood sample was collected from each person. Serum 
was separated and frozen in -20 °C freezers in plastic vials, and 
the samples were transported to the U.S. Centers for Disease 
Control (Atlanta, Georgia) on dry ice, where serum selenium 
was measured using inductively coupled plasma, with dynamic 
reaction cell, mass spectrometry (ICP-DRC-MS). The analytical 
limit of detection for assessment was 5.2 µg/L with a reference 
range of 80-300 µg/L[11].We pooled samples to make an internal 
quality control serum, and 20 quality control samples were 
randomly inserted among the other serum samples. The 
coefficient of variation in these samples was 0.04. 
The distribution of serum selenium in the four Provinces 
was not normal. Therefore we used medians and interquartile 
ranges (IQRs) to present the descriptive results and the Kruskal-
Wallis test to test the differences in serum selenium ranks among 
provinces, between males and females, and between urban and 
rural participants. The distribution of the natural logarithm of 
selenium (log selenium) in each province did not deviate from 
normal. Therefore we used linear regression to test the effect of 
age on log selenium values. We also used linear regression to 
find the proportion of variance of log selenium that was 
explained by the province. All statistical analyses were done 
using STATA® Software, version 8 (Stata Corporation, Tx). 
RESULTS 
The median age of all the study subjects was 45 years. Half of 
the subjects from each area (a total of 150) were males (Table 1). 
Half of the subjects from Ardabil and Golestan (n = 100) and all 
of the subjects from Mazandaran and Kerman (n = 100) were 
from urban areas. 
The median serum selenium concentrations were very 
different in the four Provinces. The medians (IQR) for selenium 
in Ardabil, Mazandarn, Golestan, and Kerman were 82 (75-94), 
123 (111-132), 155 (141-173), and 119 (110-128)µg/L, respectively 
(P<0.001). The results of linear regression showed that the 
province variable, by itself, explained 76% of the variance in 
log selenium (r 2 = 0.76). The proportion of these populations 
with serum selenium concentrations more than 90 µg/L (the 
concentration at which serum selenoproteins are saturated[12]) 
was 100% in Golestan, Kerman, and Mazandaran, but only 29% 
in Ardabil. 
The median (IQR) serum selenium concentrations in males 
and females were 124 (95-145) and 116 (92-143)µg/L, respectively 
(P = 0.49). 
Simple linear regression did not show a significant effect of 
age on log selenium in any of the four Provinces. The correlation 
coefficient between selenium and age in all samples combined 
was very low (r = 0.006). 
Median (IQR) serum selenium concentrations in the urban 
and rural samples of Ardabil were 81 (76-86) and 83 (74-96) µg/L, 
respectively (P= 0.57). Median (IQR) serum selenium concentrations 
in urban and rural samples from Golestan were 150 (135-165) 
and 161 (144-183) µg/L (P = 0.003). 
DISCUSSION 
Shamberger and Frost first suggested a role for selenium in the 
prevention of cancer in 1969, when they observed an inverse 
association between the geographic distribution of selenium in 
forage crops and cancer mortality rates in the United States[13]. A 
growing body of evidence, from both laboratory and epidemiologic 
studies, has since shown that selenium may have anticarcinogenic 
effects, especially against cancers of the lung, prostate, skin, 
and gastrointestinal system[14,15].
 In this study, we measured serum selenium in 300 Iranian 
adults from four provinces with varying risks of EC and GC to 
have a preliminary assessment of the hypothesis that the high 
rates of EC in Golestan and GC in Ardabil may be partly attributable 
to selenium deficiency. The proportion of the populations with 
a serum selenium more than 90 µg/L (the concentration at which 
the serum selenoproteins are saturated) was 100% in Golestan, 
Kerman, and Mazandaran, and these three provinces had 
medium to high concentrations of serum selenium compared 
with the other areas of the world. Therefore, it is unlikely that 
high incidence of EC in Golestan and Mazandaran is due to 
selenium deficiency. This is consistent with a case-control study 
in Mazandaran that did not find any difference in hair selenium 
between EC cases and controls[16]. In Ardabil, however, only 
29% of the population had a serum selenium concentration 
above 90 µg/L. This suggests that the high incidence of GC 
and pre-neoplastic gastric lesions in Ardabil[10] could be partly 
due to selenium deficiency. 
This is the first study that has examined serum selenium 
concentrations in different Iranian populations. Median serum 
selenium ranged widely, from 82 µg/L in Ardabil to 155 µg/L in 
Golestan. The median serum selenium concentration in these 
four provinces combined, weighted for the population of each 
province, was 123 µg/L. For comparison, median serum selenium 
in other areas of the world varies from very low concentrations 
(<50 µg/L) in some parts of China and Serbia to very high 
concentrations (>200 µg/L) in parts of the USA and some other 
regions of China. However, the majority of median serum 
selenium concentrations in the world range from 80-120 µg/L[17]. 
The wide range of serum selenium concentrations among 
the four provinces and its small range within each province 
was an interesting finding. The major predictor of serum 
selenium is dietary intake[14,17], and the observed differences 
Table 1  Distribution of age, sex, location, and serum selenium in study sample 
Province Number 
of samples
Median age 
(yr)
Male (%) Urban (%) Annual 
incidence of EC/105 
Annual Median serum 
incidence of GC/105  selenium (IQR) in µg/L 
Ardabil 
Mazandaran
Golestan 
Kerman
Total
100
        50
100
 50
      300 
49 
        35 
50 
33 
45
49 (49)
24 (48)
51 (51)
26 (52)
          150 (50) 
  49 (49)
  50 (100)
  51 (51) 
  50 (100)
200 (67) 
15 
    19 
40 
3
-
38 
22
18
 8
-
82 (75-94) 
123 (111-132) 
155 (141-173) 
119 (110-128) 
           1231 
1A weighted median based on the total population of each province. 
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among the provinces are most likely due to variation in the 
selenium content of their diets. 
We plan to conduct further observational studies to confirm 
or refute the association of selenium intake and the risk of GC 
in Ardabil. 
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